Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(100.0%)
2Total
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05796713Completed

Barriers to Patients' Early Presentation, Diagnosis and Treatment in Childhood Hydrocephalus

Role: collaborator

NCT04177914Phase 3Recruiting

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Role: collaborator

NCT02425761Phase 3Unknown

The CSF Shunt Entry Site Trial

Role: collaborator

NCT01797627Completed

Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus

Role: collaborator

All 4 trials loaded